A non-interventional, prospective study with benralizumab

Trial Identifier: D3250R00124
Sponsor: AstraZeneca
Collaborator:
None
Start Date: July 2024
Primary Completion Date: December 2026
Study Completion Date: December 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Ansbach, Germany
Germany Auerbach, Germany
Germany Berlin, Germany
Germany Dusseldorf, Germany
Germany Ehringshausen, Germany
Germany Heidelberg, Germany
Germany Jena, Germany
Germany Leipzig, Germany
Germany Lorrach, Germany
Germany Lubeck, Germany
Germany Markkleeberg, Germany
Germany Papenburg, Germany
Germany Rostock, Germany
Germany Saalfeld, Germany
Germany Weissenburg, Germany
Germany Wilhelmshaven, Germany
Germany Wurzburg, Germany